The United States faces a crisis in its pharmaceutical supply chain. Over 70 percent of active pharmaceutical ingredients are made overseas, with China dominating key supply chains and AI-driven manufacturing accelerating its lead. The consequences for Americans include record drug shortages, heightened national security risks, and soaring costs that threaten American patients and U.S. economic stability.

It’s time to take action. America has the technology, talent, and urgency to lead in next-generation drug manufacturing, and must make a strategic pivot toward pharmaceutical independence through economic revitalization and modernizing regulation to unshackle AI-driven innovation.

Join ITIF, Purdue University, and the National Institute for Pharmaceutical Technology and Education (NIPTE) for a summit on Capitol Hill where top leaders in AI, pharmaceutical manufacturing, and public policy will discuss what must be done.

This high-impact event will feature:

1:30 PM - 1:45 PM: Opening Remarks by Stephen Ezell and Monique K. Mansoura

1:45 PM - 2:15 PM: Expert Panel Discussion moderated by Purdue University President Mung Chiang

2:15 PM - 2:20 PM: Remarks by Senator Todd Young (R-IN)

2:20 PM - 3:00 PM: Expert Panel Discussion Resumes

3:00 PM - 3:30 PM: Historic Accord Signing to drive a national strategy for securing U.S. medicines production.

Speakers

Stephen Ezell
Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation
Information Technology and Innovation Foundation
Host

Mung Chiang
President
Purdue University
Moderator

Todd Young
Senator (R-IN)
U.S. Congress
Speaker

Monique K. Mansoura
Global Health Security & Biotechnology, Strategic Advisor
Speaker

Andrew Carpenter
Chief Scientific Officer
Phlow
Panelist

Manish Oza, MD
Industry Executive, Healthcare and Life Sciences
Google
Panelist

David A. Ricks
Chair and Chief Executive Officer
Eli Lilly and Company
Panelist

William D. Young
Senior Advisor
Blackstone Life Sciences
Panelist